BR112014028280A2 - composições farmacêuticas tópicas compreendendo terbinafina e ureia - Google Patents
composições farmacêuticas tópicas compreendendo terbinafina e ureiaInfo
- Publication number
- BR112014028280A2 BR112014028280A2 BR112014028280A BR112014028280A BR112014028280A2 BR 112014028280 A2 BR112014028280 A2 BR 112014028280A2 BR 112014028280 A BR112014028280 A BR 112014028280A BR 112014028280 A BR112014028280 A BR 112014028280A BR 112014028280 A2 BR112014028280 A2 BR 112014028280A2
- Authority
- BR
- Brazil
- Prior art keywords
- terbinafine
- urea
- pharmaceutical compositions
- topical pharmaceutical
- topical
- Prior art date
Links
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 title 1
- 239000004202 carbamide Substances 0.000 title 1
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 title 1
- 229960002722 terbinafine Drugs 0.000 title 1
- 239000012049 topical pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261646650P | 2012-05-14 | 2012-05-14 | |
EP20120003791 EP2664327A1 (en) | 2012-05-14 | 2012-05-14 | Topical pharmaceutical compositions comprising terbinafide and urea |
PCT/EP2013/059814 WO2013171159A1 (en) | 2012-05-14 | 2013-05-13 | Topical pharmaceutical compositions comprising terbinafine and urea |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112014028280A2 true BR112014028280A2 (pt) | 2019-09-24 |
Family
ID=46148606
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014028280A BR112014028280A2 (pt) | 2012-05-14 | 2013-05-13 | composições farmacêuticas tópicas compreendendo terbinafina e ureia |
Country Status (20)
Country | Link |
---|---|
US (1) | US20150111971A1 (pt) |
EP (2) | EP2664327A1 (pt) |
JP (1) | JP2015516455A (pt) |
KR (1) | KR20150013162A (pt) |
CN (1) | CN104302281A (pt) |
AR (1) | AR091039A1 (pt) |
AU (1) | AU2013261918A1 (pt) |
BR (1) | BR112014028280A2 (pt) |
CA (1) | CA2872210A1 (pt) |
CL (1) | CL2014003081A1 (pt) |
CO (1) | CO7131352A2 (pt) |
EA (1) | EA201492091A1 (pt) |
HK (1) | HK1202808A1 (pt) |
IL (1) | IL235241A0 (pt) |
MX (1) | MX2014013851A (pt) |
PH (1) | PH12014502512A1 (pt) |
SG (1) | SG11201407536UA (pt) |
TW (1) | TW201350107A (pt) |
WO (1) | WO2013171159A1 (pt) |
ZA (1) | ZA201407655B (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201317005D0 (en) * | 2013-09-25 | 2013-11-06 | Blueberry Therapeutics Ltd | Composition and methods of treatment |
PL3209319T3 (pl) | 2014-10-21 | 2021-12-20 | Hexima Limited | Sposób leczenia zakażeń grzybiczych |
GB201605127D0 (en) * | 2016-03-25 | 2016-05-11 | Blueberry Therapeutics Ltd | Composition and methods of treatment |
AU2018221880B2 (en) * | 2017-02-15 | 2023-08-17 | Botanix Pharmaceuticals Ltd | Formulations of cannabinoids for the treatment of dermatitis and inflammatory skin diseases |
EP3492068A1 (en) * | 2017-12-01 | 2019-06-05 | NCP NewCare Products GmbH | Composition for treating onychomycosis |
WO2019214838A1 (en) * | 2018-05-09 | 2019-11-14 | Eviderm Institute Ab | Use of an alcohol-containing composition for improving the skin barrier function |
PL245223B1 (pl) * | 2019-01-10 | 2024-06-03 | Biotts Spolka Akcyjna | Nośnik farmaceutyczny dla substancji czynnych oraz kompozycja farmaceutyczna go zawierająca |
JP6591100B1 (ja) * | 2019-01-25 | 2019-10-16 | ロート製薬株式会社 | 爪及び爪周り用医薬組成物 |
WO2024038427A1 (en) * | 2022-08-17 | 2024-02-22 | Lyotropic Delivery Systems Ltd. | Topical delivery of antifungal agents for treating fungal infections |
KR102597564B1 (ko) * | 2023-03-03 | 2023-11-03 | 장병모 | 조갑 및 피부 백선의 예방 또는 치료용 약학적 조성물 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6281239B1 (en) * | 2000-04-12 | 2001-08-28 | Bradley Pharmeaceuticals, Inc. | Method of treating onychomycosis |
WO2011014850A2 (en) * | 2009-07-31 | 2011-02-03 | Nuvo Research Inc. | Topical eutectic-based formulations |
WO2011079234A2 (en) * | 2009-12-23 | 2011-06-30 | Nuvo Research Inc. | Highly permeating terbinafine formulation |
-
2012
- 2012-05-14 EP EP20120003791 patent/EP2664327A1/en not_active Withdrawn
-
2013
- 2013-05-13 AU AU2013261918A patent/AU2013261918A1/en not_active Abandoned
- 2013-05-13 SG SG11201407536UA patent/SG11201407536UA/en unknown
- 2013-05-13 CN CN201380025181.7A patent/CN104302281A/zh active Pending
- 2013-05-13 US US14/398,875 patent/US20150111971A1/en not_active Abandoned
- 2013-05-13 MX MX2014013851A patent/MX2014013851A/es unknown
- 2013-05-13 WO PCT/EP2013/059814 patent/WO2013171159A1/en active Application Filing
- 2013-05-13 EP EP13722416.8A patent/EP2849739A1/en not_active Withdrawn
- 2013-05-13 TW TW102116868A patent/TW201350107A/zh unknown
- 2013-05-13 EA EA201492091A patent/EA201492091A1/ru unknown
- 2013-05-13 JP JP2015512013A patent/JP2015516455A/ja active Pending
- 2013-05-13 BR BR112014028280A patent/BR112014028280A2/pt not_active IP Right Cessation
- 2013-05-13 CA CA 2872210 patent/CA2872210A1/en not_active Abandoned
- 2013-05-13 KR KR20147031487A patent/KR20150013162A/ko not_active Application Discontinuation
- 2013-05-14 AR ARP130101657 patent/AR091039A1/es unknown
-
2014
- 2014-10-21 IL IL235241A patent/IL235241A0/en unknown
- 2014-10-21 ZA ZA2014/07655A patent/ZA201407655B/en unknown
- 2014-11-11 PH PH12014502512A patent/PH12014502512A1/en unknown
- 2014-11-13 CO CO14251765A patent/CO7131352A2/es unknown
- 2014-11-13 CL CL2014003081A patent/CL2014003081A1/es unknown
-
2015
- 2015-04-08 HK HK15103459.1A patent/HK1202808A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CN104302281A (zh) | 2015-01-21 |
HK1202808A1 (en) | 2015-10-09 |
KR20150013162A (ko) | 2015-02-04 |
CA2872210A1 (en) | 2013-11-21 |
ZA201407655B (en) | 2015-06-24 |
PH12014502512A1 (en) | 2014-12-22 |
SG11201407536UA (en) | 2014-12-30 |
EP2849739A1 (en) | 2015-03-25 |
AR091039A1 (es) | 2014-12-30 |
AU2013261918A1 (en) | 2014-11-06 |
EP2664327A1 (en) | 2013-11-20 |
EA201492091A1 (ru) | 2015-03-31 |
CO7131352A2 (es) | 2014-12-01 |
IL235241A0 (en) | 2014-12-31 |
TW201350107A (zh) | 2013-12-16 |
CL2014003081A1 (es) | 2015-03-27 |
WO2013171159A1 (en) | 2013-11-21 |
MX2014013851A (es) | 2015-02-12 |
JP2015516455A (ja) | 2015-06-11 |
US20150111971A1 (en) | 2015-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL289759A (en) | Formulations for local disinfection and their uses | |
BR112015002738A2 (pt) | composto , e , composição farmacêutica | |
BR112014028280A2 (pt) | composições farmacêuticas tópicas compreendendo terbinafina e ureia | |
DK2925293T3 (da) | Topiske tetracyclinformuleringer, fremstilling og anvendelser deraf | |
BR112014029403A2 (pt) | conjugados, anticorpo e formulação farmacêutica | |
DK3278792T3 (da) | Lægemiddelformulering med forsinket udløsning | |
BR112014012005A2 (pt) | composições, métodos, formulação farmacêutica e artigo | |
CL2014002051A1 (es) | Composiciones plaguicidas y procesos relacionados con dichas composiones | |
BR112013014644A2 (pt) | composição farmacêutica e complexo | |
BR112015011111A2 (pt) | proteína multifuncional e formulação farmacêutica | |
BR112014010290A2 (pt) | composição farmacêutica, métodos, composições e usos | |
DK2897594T3 (da) | Farmaceutisk sammensætning | |
DK2809669T3 (da) | Kondenserede pyrroldicarboxamider og deres anvendelse som farmaceutika | |
CY2200004T2 (el) | Σκευασματα δαπτομυκινης και χρησεις αυτων | |
BR112015007217A2 (pt) | compostos e usos do composto | |
CL2014002951A1 (es) | (r)-nifuratel; formulacion farmaceutica que lo contiene; y proceso para fabricar (r)-nifuratel y (s)-nifuratel. | |
DK3156060T3 (da) | Farmaceutiske sammensætninger og topisk anvendelse deraf | |
CO7000772A2 (es) | Composiciones farmacéuticas tópicas que comprenden bexaroteno y corticosteroides | |
BR112015002646A2 (pt) | composto e composição farmacêutica | |
DK3473255T3 (da) | Farmaceutisk formulering omfattende ciclesonid | |
HK1213813A1 (zh) | 種含埃克替尼的皮膚外用藥物組合物及其應用 | |
BR112014009501A2 (pt) | organogel e com´posição cosmética | |
BR112014016122A8 (pt) | composto, e, composição farmacêutica | |
BR112014017217A2 (pt) | agente e composição farmacêutica | |
CO6990712A2 (es) | Combinación farmacéutica antineuritica y composiciones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |